J. Safra Sarasin Holding Ag Annexon, Inc. Transaction History
J. Safra Sarasin Holding Ag
- $5.79 Trillion
- Q2 2025
A detailed history of J. Safra Sarasin Holding Ag transactions in Annexon, Inc. stock. As of the latest transaction made, J. Safra Sarasin Holding Ag holds 381,441 shares of ANNX stock, worth $930,716. This represents 0.02% of its overall portfolio holdings.
Number of Shares
381,441
Previous 254,538
49.86%
Holding current value
$930,716
Previous $491 Million
86.35%
% of portfolio
0.02%
Previous 0.01%
Shares
3 transactions
Others Institutions Holding ANNX
# of Institutions
147Shares Held
96.6MCall Options Held
36.9KPut Options Held
83K-
Satter Management Co., L.P.7.41MShares$18.1 Million71.99% of portfolio
-
Bvf Inc San Francisco, CA7MShares$17.1 Million0.59% of portfolio
-
Black Rock Inc. New York, NY6.59MShares$16.1 Million0.0% of portfolio
-
Redmile Group, LLC San Francisco, CA6.3MShares$15.4 Million1.28% of portfolio
-
Vanguard Group Inc Valley Forge, PA5.37MShares$13.1 Million0.0% of portfolio
About Annexon, Inc.
- Ticker ANNX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 47,617,700
- Market Cap $116M
- Description
- Annexon, Inc., a clinical-stage biopharmaceutical company, discovers and develops therapeutics for autoimmune, neurodegenerative, and ophthalmic disorders. The company's C1q is an initiating molecule of the classical complement pathway that targets distinct disease processes, such as antibody-mediated autoimmune disease and complement-mediated n...